Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is a common hair loss condition influenced by various factors and linked to psychosocial and cardiovascular issues.

Using different hair loss treatments at various times can improve results and reduce side effects for people with chronic hair loss.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Dihydroartemisinin helps reduce prostate enlargement in rats by stopping the growth of prostate cells.

Hair loss is more common in male Chinese college freshmen, and it's linked with rosacea but doesn't affect their quality of life.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Androgenetic alopecia negatively affects quality of life, especially in younger, less educated, single, and rural individuals.

People with early-onset androgenetic alopecia may have a higher risk of heart disease due to abnormal blood lipid levels.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Combining PRP with Minoxidil improves hair density and thickness more than Minoxidil alone.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

New regenerative therapies show promise for treating hair loss.

Paris polyphylla saponins may effectively treat acne due to their antibacterial and anti-inflammatory properties.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Testosterone is linked to cardiovascular risk factors and stroke, but its exact role is unclear.

Stress can cause hair loss by affecting nerve-related hair growth, and noradrenaline might help prevent this.

Origanum vulgare leaf extract reduces liver and kidney damage caused by finasteride in mice.

Menopause can cause hair thinning and texture changes due to hormonal and metabolic shifts.

Social media data can help track COVID-19 symptoms and predict the pandemic's status.

Male and female pattern hair loss have different molecular pathways, suggesting unique treatment targets for each sex.

Alopecia areata causes hair loss and life quality issues; current treatments are often unsatisfactory, but new drugs like JAK inhibitors show promise.

Many people experienced hair loss after having COVID-19, with the worst cases in hospitalized patients, and some saw hair regrowth within six months.

ERG increases SOX9, promoting prostate cancer growth and invasion.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.